Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
Clinical trial NCT07521631 · RECRUITING
Trial details
- NCT number
- NCT07521631
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2027-02-04
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.